Consumer Medicine Information (CMI) summary
The
full CMI on the next page has more details. If you are worried about using this medicine,
speak to your doctor or pharmacist.
1. Why am I receiving Kyprolis?
Kyprolis contains the active ingredient carfilzomib. Kyprolis is used to treat multiple
myeloma (cancer of the bone marrow) that has come back after, or not responded to,
previous treatment.
2. What should I know before I am given Kyprolis?
Do not use if you have ever had an allergic reaction to carfilzomib or any of the
ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding.
3. What if I am taking other medicines?
Some medicines may interfere with Kyprolis and affect how it works.
4. How will I be given Kyprolis?
You will be given Kyprolis as an infusion (slow injection or "drip" into a vein) once-
or twice-weekly for 3 weeks followed by 1 week off treatment. Your doctor will decide
how long you will receive Kyprolis for.
5. What should I know during treatment with Kyprolis?
Things you should do
|
Remind any doctor, nurse, dentist or pharmacist you visit that you are using Kyprolis
Keep all your treatment and doctor's appointments so that your progress can be checked
Tell your doctor immediately if you become pregnant while taking Kyprolis
|
Things you should not do
|
Do not breastfeed during Kyprolis treatment
|
Driving or using machines
|
Do not drive or operate machinery or engage in hazardous activities while you are
taking Kyprolis if you experience fatigue, dizziness and/or fainting
|
6. Are there any side effects?
Side effects that require urgent medical attention include: signs of an allergic reaction,
such as rash, difficulty breathing, swelling of face, lips, throat and tongue or other
part of the body, rapid pulse or sweating; chest pain, breathing problems.
Very common side effects include: headache, aches or pains in joints or muscles, dizziness,
difficulty sleeping, infections in the nasal or throat passages or lung, high blood
pressure, breathlessness, cough, diarrhoea/constipation, feeling sick, vomiting, fever,
fatigue.
Active ingredient(s): Carfilzomib (kar-FILZ-oh-mib)
Full Consumer Medicine Information (CMI)
This leaflet provides important information about using Kyprolis. You should also speak to your doctor or pharmacist if you would like further information
or if you have any concerns or questions about using Kyprolis.
Where to find information in this leaflet:
1. Why am I receiving Kyprolis?
Kyprolis contains the active ingredient carfilzomib.
Kyprolis is an anti-cancer medicine used to treat multiple myeloma (cancer of the
bone marrow) that has come back after or not responded to previous treatment.
Kyprolis will be given to you in combination with other medicines that are also used
to treat multiple myeloma.
2. What should I know before I am given Kyprolis?
Warnings
Do not use Kyprolis if you are allergic to:
Any medicine containing carflizomib, or any of the ingredients listed at the end of
this leaflet.
Always check the ingredients to make sure you can use this medicine.
Check with your doctor if you:
Have allergies to any other medicines, foods, preservatives or dyes.
Have or have had any other medical conditions including:
heart problems, including a history of chest pain (angina), heart attack, irregular
heartbeat, high blood pressure, or if you have ever taken a medicine for your heart
lung problems, including a history of shortness of breath at rest or with activity
kidney problems, including kidney failure or if you have ever received dialysis
liver problems, including a history of hepatitis, fatty liver of if you have ever
been told your liver is not working properly
bleeding or bruising more easily than normal
blood clots in your veins and small blood vessels
any other major disease for which you were hospitalised or received medication.
Take any medicines for any other condition.
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section
6. Are there any side effects?
Pregnancy
Check with your doctor if you are pregnant or intend to become pregnant. Kyprolis
is not recommended to be used during pregnancy. Women receiving Kyprolis must use
a reliable method of birth control during and for 1 month after receiving Kyprolis.
Men receiving Kyprolis must use a reliable method of birth control during and for
3 months after receiving Kyprolis.
Tell your doctor immediately if you become pregnant while using Kyprolis, or within
1 month of stopping treatment with Kyprolis or, if you are a man receiving Kyprolis,
if your partner becomes pregnant whilst you are using Kyprolis or within 3 months
of you stopping treatment with Kyprolis.
Breastfeeding
Talk to your doctor if you are breastfeeding or intend to breastfeed. Kyprolis is
not recommended for use if you are breastfeeding. It is not known if the active ingredient
in Kyprolis passes into breast milk. A decision on whether to discontinue breastfeeding
or discontinue therapy with Kyprolis should be made.
Your doctor can discuss the risks and benefits with you.
3. What if I am taking other medicines?
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Tell your doctor or pharmacist if you are taking medicines used to prevent pregnancy,
including oral and hormonal contraceptives.
Read the CMI leaflets of all medicines you take in combination with Kyprolis. This
will help you understand the information related to those medicines.
Some medicines may interfere with Kyprolis and affect how it works. You may need to use different amounts of your medicines or take different medicines.
Check with your doctor or pharmacist if you are not sure about what medicines, vitamins
or supplements you are taking and if these affect Kyprolis.
4. How will I be given Kyprolis?
When you will be given Kyprolis
You will be given Kyprolis either once weekly or twice weekly by a healthcare professional.
Your doctor will decide which regimen is best suited for you. One treatment cycle
lasts 28 days.
Kyprolis once weekly is given each week for 3 weeks, followed by a 1-week break. Kyprolis
is usually given on days 1, 8 and 15.
Kyprolis twice weekly is given 2 days in a row, each week for 3 weeks, followed by
a 1-week break. Kyprolis is usually given on days 1, 2, 8, 9, 15 and 16.
How much Kyprolis will you be given
Your doctor will determine the dose of Kyprolis you receive which will be calculated
based on your height and weight (body surface area).
How is Kyprolis given
Kyprolis is dissolved in sterile water for injections and the solution is given as
an infusion into your vein; this is called an intravenous (IV) infusion. Treatment
with Kyprolis will be under the supervision of a doctor, and your treatment will be
given to you by a doctor or nurse.
How long to take Kyprolis
Your doctor will decide how long you will take Kyprolis. This will depend on how well
you respond to treatment.
If you are given too much Kyprolis
Kyprolis will be given to you by your doctor or nurse, your doctor will treat and
monitor your side effects.
5. What should I know during treatment with Kyprolis?
Things you should do
Keep all your doctor's appointments so that your progress can be checked. Your doctor
may do blood tests to check on your progress and detect any unwanted side effects.
Tell your doctor immediately if you become pregnant while taking Kyprolis.
Remind any doctor, nurse, dentist or pharmacist you visit that you are using Kyprolis.
Call your doctor straight away if you have:
Chest pain, shortness of breath, or if there is swelling of your ankles and feet,
shortness of breath with everyday activities or at rest, irregular heartbeat, racing
pulse, tiredness, dizziness, and fainting spells which may be symptoms of heart problems
Difficulty breathing, including shortness of breath at rest or with activity or a
cough, rapid breathing, wheezing, or cough.
Severe chest pain, severe headache, confusion, blurred vision, nausea and vomiting,
or severe anxiety
Swollen ankles, feet, or hands; loss of appetite; passing less urine; or abnormal
blood tests, which may be symptoms of kidney problems or kidney failure
A reaction at any time during your infusion, symptoms may include fever, chills or
shaking, joint pain, muscle pain, facial flushing or swelling, weakness, shortness
of breath, fainting, chest tightness or pain
Unusual bruising or bleeding, such as a cut that does not stop bleeding in a normal
amount of time or internal bleeding such as coughing up blood, vomiting up blood,
dark tarry stools, or bright red blood in your stools
Leg pain, chest pain or shortness of breath (which may be a symptom of blood clots)
Yellowing of your skin and eyes, abdominal pain or swelling, nausea or vomiting.
Headaches, confusion, seizures, visual loss, and high blood pressure,
Blurred or double vision, vision loss, difficulty speaking, weakness in an arm or
leg, a change in the way you walk, problems with your balance, persistent numbness,
decreased or loss of sensation, memory loss or confusion.
Things you should not do
Do not breastfeed during Kyprolis treatment
Do not miss your appointment. Keep all of your doctor's appointments so that your
progress can be checked.
Driving or using machines
Be careful before you drive or use any machines or tools until you know how Kyprolis
affects you.
Kyprolis may cause fatigue, dizziness and/or fainting in some people. If you have
any of these symptoms, do not drive or operate machinery or engage in hazardous activities.
Looking after your medicine
Kyprolis will be prepared for your infusion by your health care team.
Getting rid of any unwanted medicine
Your doctor or nurse will dispose of this medicine.
6. Are there any side effects?
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
See the information below and, if you need to, ask your doctor or pharmacist if you
have any further questions about side effects.
Less serious side effects
Serious side-effects
Tell your doctor or pharmacist if you notice anything else that may be making you
feel unwell.
Other side effects not listed here may occur in some people.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at
www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine.
Always make sure you speak to your doctor or pharmacist before you decide to stop
taking any of your medicines.
7. Product details
This medicine is only available with a doctor's prescription.
What Kyprolis contains
Active ingredient
(main ingredient)
|
Carfilzomib
|
Other ingredients
(inactive ingredients)
|
Sulfobutyl betadex sodium
Citric acid
Sodium hydroxide
|
Do not take this medicine if you are allergic to any of these ingredients.
What Kyprolis looks like
Kyprolis is supplied as a white-to-off-white powder in a glass vial.
Each pack contains one single-use vial.
60 mg carfilzomib in Kyprolis 60 mg vial (Aust R 283228).
30 mg carfilzomib in Kyprolis 30 mg vial (Aust R 266773).
10 mg carfilzomib in Kyprolis 10 mg vial (Aust R 288527).
Who distributes Kyprolis?
Amgen Australia Pty Ltd.,
Level 11, 10 Carrington Street
Sydney NSW 2000.
Ph: 1800 803 638
® indicates a registered trademark of Onyx Pharmaceuticals, Inc., a subsidiary of Amgen
Inc.
This leaflet was prepared in March 2023.